Feasibility and outcome of the Rotapro system in treating severely calcified coronary lesions: The Rotapro study.

The present study demonstrates the safety and efficacy of the new Rotapro system. In-hospital MACCE rates were comparable between both RAS, whereas Rotapro was associated with less fluoroscopy time, radiation dose as well as contrast use.